Suppr超能文献

在喹吡罗致敏的强迫症(OCD)大鼠模型中,5-羟色胺2A/C受体并不介导mCPP对强迫检查行为的减弱作用。

5-HT2A/C receptors do not mediate the attenuation of compulsive checking by mCPP in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD).

作者信息

Tucci Mark C, Dvorkin-Gheva Anna, Johnson Eric, Wong Michael, Szechtman Henry

机构信息

Department of Psychiatry and Behavioural Neurosciences, McMaster University, HSC, 4N7, 1280 Main Street West, Hamilton, ON, Canada L8S4L8.

Department of Psychiatry and Behavioural Neurosciences, McMaster University, HSC, 4N7, 1280 Main Street West, Hamilton, ON, Canada L8S4L8.

出版信息

Behav Brain Res. 2015 Feb 15;279:211-7. doi: 10.1016/j.bbr.2014.11.017. Epub 2014 Nov 15.

Abstract

There is emerging evidence for a dopamine (DA)-serotonin (5-HT) interaction underlying obsessive-compulsive disorder (OCD). In the quinpirole sensitization rat model of OCD, compulsive checking is induced by chronic treatment with the DA agonist quinpirole, and is attenuated by the 5-HT agonist drug mCPP. However, mCPP has affinity for a number of 5-HT receptor subtypes, and it is unknown by which receptors mCPP exerts its effects on quinpirole-treated animals. The present study tested in rats whether mCPP activity at 5-HT2A/C receptors mediates the attenuation of compulsive checking in quinpirole-treated animals. Rats were chronically treated with quinpirole on the open field for the induction of compulsive checking. Following the induction phase, animals were treated with mCPP (1.25 mg/kg) and the selective 5-HT2A/C receptor antagonist ritanserin (1 mg/kg or 5 mg/kg) to test whether blockade of 5-HT2A/C receptors inhibits attenuation of checking by mCPP. Results showed that as expected, quinpirole induced compulsive checking, and mCPP reduced its performance. However, 5-HT2A/C receptor blockade by ritanserin did not inhibit the attenuation of compulsive checking by mCPP. These results suggest that the reduction in compulsive checking by mCPP is not mediated by activity at 5-HT2A/C receptors, but by another receptor subtype.

摘要

有新证据表明,强迫症(OCD)背后存在多巴胺(DA)-血清素(5-HT)相互作用。在强迫症的喹吡罗致敏大鼠模型中,DA激动剂喹吡罗的长期治疗会诱发强迫性检查行为,而5-HT激动剂药物mCPP可减弱这种行为。然而,mCPP对多种5-HT受体亚型具有亲和力,目前尚不清楚mCPP是通过哪些受体对喹吡罗治疗的动物产生作用的。本研究在大鼠中测试了mCPP在5-HT2A/C受体上的活性是否介导了喹吡罗治疗动物强迫性检查行为的减弱。大鼠在旷场中接受喹吡罗长期治疗以诱发强迫性检查行为。在诱导期之后,给动物注射mCPP(1.25毫克/千克)和选择性5-HT2A/C受体拮抗剂利坦色林(1毫克/千克或5毫克/千克),以测试阻断5-HT2A/C受体是否会抑制mCPP对检查行为的减弱作用。结果表明,正如预期的那样,喹吡罗诱发了强迫性检查行为,而mCPP降低了这种行为的表现。然而,利坦色林对5-HT2A/C受体 的阻断并没有抑制mCPP对强迫性检查行为的减弱作用。这些结果表明,mCPP对强迫性检查行为的减弱作用不是由其在5-HT2A/C受体上的活性介导的,而是由另一种受体亚型介导的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验